Literature DB >> 35707442

Interval-censored data with misclassification: a Bayesian approach.

Magda Carvalho Pires1, Enrico Antônio Colosimo1, Guilherme Augusto Veloso1, Raquel de Souza Borges Ferreira1.   

Abstract

Survival data involving silent events are often subject to interval censoring (the event is known to occur within a time interval) and classification errors if a test with no perfect sensitivity and specificity is applied. Considering the nature of this data plays an important role in estimating the time distribution until the occurrence of the event. In this context, we incorporate validation subsets into the parametric proportional hazard model, and show that this additional data, combined with Bayesian inference, compensate the lack of knowledge about test sensitivity and specificity improving the parameter estimates. The proposed model is evaluated through simulation studies, and Bayesian analysis is conducted within a Gibbs sampling procedure. The posterior estimates obtained under validation subset models present lower bias and standard deviation compared to the scenario with no validation subset or the model that assumes perfect sensitivity and specificity. Finally, we illustrate the usefulness of the new methodology with an analysis of real data about HIV acquisition in female sex workers that have been discussed in the literature.
© 2020 Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  Bayesian inference; interval-censored data; misclassification; survival analysis; validation subsets

Year:  2020        PMID: 35707442      PMCID: PMC9041936          DOI: 10.1080/02664763.2020.1753025

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.416


  18 in total

1.  Estimation of the timing of perinatal transmission of HIV.

Authors:  R Balasubramanian; S W Lagakos
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Nonparametric and Semiparametric Analysis of Current Status Data Subject to Outcome Misclassification.

Authors:  Victor G Sal Y Rosas; James P Hughes
Journal:  Stat Commun Infect Dis       Date:  2010-04-21

3.  Analysis of progression-free survival data using a discrete time survival model that incorporates measurements with and without diagnostic error.

Authors:  Sally Hunsberger; Paul S Albert; Lori Dodd
Journal:  Clin Trials       Date:  2010-11-25       Impact factor: 2.486

4.  Assessing treatment effects with surrogate survival outcomes using an internal validation subsample.

Authors:  Jarcy Zee; Sharon X Xie
Journal:  Clin Trials       Date:  2015-05-14       Impact factor: 2.486

5.  Marginal Bayesian Semiparametric Modeling of Mismeasured Multivariate Interval-Censored Data.

Authors:  Li Li; Alejandro Jara; María José García-Zattera; Timothy E Hanson
Journal:  J Am Stat Assoc       Date:  2018-10-26       Impact factor: 5.033

6.  Modelling the cumulative risk for a false-positive under repeated screening events.

Authors:  A E Gelfand; F Wang
Journal:  Stat Med       Date:  2000-07-30       Impact factor: 2.373

7.  Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample.

Authors:  Jarcy Zee; Sharon X Xie
Journal:  Biometrics       Date:  2015-04-27       Impact factor: 2.571

8.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.

Authors:  H L Martin; P M Nyange; B A Richardson; L Lavreys; K Mandaliya; D J Jackson; J O Ndinya-Achola; J Kreiss
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

9.  Incorporating validation subsets into discrete proportional hazards models for mismeasured outcomes.

Authors:  Amalia S Magaret
Journal:  Stat Med       Date:  2008-11-20       Impact factor: 2.373

10.  SEMIPARAMETRIC TIME TO EVENT MODELS IN THE PRESENCE OF ERROR-PRONE, SELF-REPORTED OUTCOMES-WITH APPLICATION TO THE WOMEN'S HEALTH INITIATIVE.

Authors:  Xiangdong Gu; Yunsheng Ma; Raji Balasubramanian
Journal:  Ann Appl Stat       Date:  2015-06       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.